Objective of the project:
Inflammatory bowel disease (IBD), including the Crohn´s disease, is one of the most important civilization disorder nowadays. Algae4IBD’s mission is to discover algal and cyanobacterial bioactive compounds reducing the inflammatory response and simultaneously silencing other IBD symptoms. The biomass of algal strains producing such compound will be used for preparation of functional food used in treatment and prevention of IBD. International consortium led by Israeli colleagues includes scientist from 21 European institutions with different expertise ranging from natural product chemistry, pharmacology, drug administration to functional food preparation.
| Acronym | Algae4IBD | |
| Number and ID code of the project | N° 101000501, H2020-FNR-2020-2 | |
| Type of the project | RIA | |
| Coordinator | MIGAL GALILEE RESEARCH INSTITUTE LTD, Israel | |
| IMIC Principal Researcher | RNDr. Pavel Hrouzek, Ph.D. | |
| Start of the project | 6/2021 | |
| End of the project | 5/2025 | |
| Total number of particip. countries | 11 | |
| Of which from EU | 9 | |
| Number of partners | 20 | |
| Total funding for the project | 7 499 520,01 EUR | |
| Funding for IMIC | 271 995 EUR | |
| Provider | Program EU Horizon 2020 FNR-11-2020 – Prospecting aquatic and terrestrial natural biological |